These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Nitric oxide in CsA-induced hypertension: role of beta-adrenoceptor antagonist and thromboxane A2. Oriji GK; Schanz N Prostaglandins Leukot Essent Fatty Acids; 2001; 65(5-6):259-63. PubMed ID: 11993718 [TBL] [Abstract][Full Text] [Related]
3. Role of nitric oxide in cyclosporine A-induced hypertension. Oriji GK; Keiser HR Hypertension; 1998 Nov; 32(5):849-55. PubMed ID: 9822443 [TBL] [Abstract][Full Text] [Related]
4. Nitric oxide in cyclosporine A-induced hypertension: role of protein kinase C. Oriji GK; Keiser HR Am J Hypertens; 1999 Nov; 12(11 Pt 1):1091-7. PubMed ID: 10604485 [TBL] [Abstract][Full Text] [Related]
5. Vascular changes in cyclosporine A-induced hypertension and nephrotoxicity in spontaneously hypertensive rats on high-sodium diet. Lassila M; Santisteban J; Finckenberg P; Salmenperä P; Riutta A; Moilanen E; Virtanen I; Vapaatalo H; Nurminen ML J Physiol Pharmacol; 2001 Mar; 52(1):21-38. PubMed ID: 11321510 [TBL] [Abstract][Full Text] [Related]
6. Cyclosporine A-induced increase in glomerular cyclic GMP in rats and the involvement of the endothelinB receptor. Tack I; Marin-Castano E; Bascands JL; Pecher C; Ader JL; Girolami JP Br J Pharmacol; 1997 Jun; 121(3):433-40. PubMed ID: 9179384 [TBL] [Abstract][Full Text] [Related]
7. Role of metoprolol, B1-adrenoceptor antagonist, thromboxane A2 and nitric oxide in CsA-induced hypertension. Oriji GK Prostaglandins Leukot Essent Fatty Acids; 2003 Mar; 68(3):233-8. PubMed ID: 12591008 [TBL] [Abstract][Full Text] [Related]
8. Nitric oxide production modulates cyclosporin A-induced distal renal tubular acidosis in the rat. Tsuruoka S; Schwartz GJ; Wakaumi M; Nishiki K; Yamamoto H; Purkerson JM; Fujimura A J Pharmacol Exp Ther; 2003 Jun; 305(3):840-5. PubMed ID: 12626650 [TBL] [Abstract][Full Text] [Related]
9. Angiotensin-converting enzyme inhibition and angiotensin AT1-receptor antagonism equally improve endothelial vasodilator function in L-NAME-induced hypertensive rats. De Gennaro Colonna V; Rigamonti A; Fioretti S; Bonomo S; Manfredi B; Ferrario P; Bianchi M; Berti F; Muller EE; Rossoni G Eur J Pharmacol; 2005 Jun; 516(3):253-9. PubMed ID: 15963975 [TBL] [Abstract][Full Text] [Related]
10. Pomace olive oil improves endothelial function in spontaneously hypertensive rats by increasing endothelial nitric oxide synthase expression. Rodriguez-Rodriguez R; Herrera MD; de Sotomayor MA; Ruiz-Gutierrez V Am J Hypertens; 2007 Jul; 20(7):728-34. PubMed ID: 17586406 [TBL] [Abstract][Full Text] [Related]
11. [Effect of spironolactone on L-arginine/iNOS/NO pathway of aortic adventitia in spontaneously hypertensive rats]. Deng CN; Shen LH; Tang CS Zhonghua Yi Xue Za Zhi; 2010 Feb; 90(6):424-6. PubMed ID: 20367944 [TBL] [Abstract][Full Text] [Related]
12. Comparative interaction of few antihypertensive drugs with cyclosporine-A in rats. Kumar NP; Inamdar MN; Venkataraman BV Indian J Exp Biol; 2007 Jul; 45(7):638-41. PubMed ID: 17821861 [TBL] [Abstract][Full Text] [Related]
13. Effect of molsidomine and L-arginine in cyclosporine nephrotoxicity: role of nitric oxide. Chander V; Chopra K Toxicology; 2005 Feb; 207(3):463-74. PubMed ID: 15664273 [TBL] [Abstract][Full Text] [Related]
14. Treatment with the arginase inhibitor N(omega)-hydroxy-nor-L-arginine improves vascular function and lowers blood pressure in adult spontaneously hypertensive rat. Bagnost T; Berthelot A; Bouhaddi M; Laurant P; André C; Guillaume Y; Demougeot C J Hypertens; 2008 Jun; 26(6):1110-8. PubMed ID: 18475148 [TBL] [Abstract][Full Text] [Related]
15. Blockade of endothelin ET(A), but not thromboxane, receptors offsets the cyclosporine-evoked hypertension and interrelated baroreflex and vascular dysfunctions. Nasser SA; Elmallah AI; Sabra R; Khedr MM; El-Din MM; El-Mas MM Eur J Pharmacol; 2014 Mar; 727():52-9. PubMed ID: 24486390 [TBL] [Abstract][Full Text] [Related]
16. Vascular effects of long-term propranolol administration after chronic nitric oxide blockade. Priviero FB; Teixeira CE; Claudino MA; De Nucci G; Zanesco A; Antunes E Eur J Pharmacol; 2007 Oct; 571(2-3):189-96. PubMed ID: 17610863 [TBL] [Abstract][Full Text] [Related]